People with diabetes who use ReliOn insulin syringes should check their syringe package because of an important recall. Tyco Healthcare Group (Covidien) is recalling 4,710 boxes of the syringes -- ...
Earlier syringe development may cut time-to-market, increase clinical trial appeal Ravensburg, Germany, April 9, 2014 / B3C newswire / – Vetter, a leading contract development and manufacturing ...
People with diabetes who use ReliOn insulin syringes should check their syringe package because of an important recall. Tyco Healthcare Group (Covidien) is recalling 4,710 boxes of the syringes - with ...
Vetter has introduced two clinical syringe packages that make it easier to start syringe development earlier in the drug development process. Starting syringe work earlier, in full or partial parallel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback